Clinical trial

Human brain
#Clinical trial #Neuroscience #Newron Pharmaceuticals #Schizophrenia #Treatment resistance

“Highly encouraging” results for schizophrenia drug

Milan-based Newron Pharmaceuticals has reported “exceptional” one-year results from study 014/15 into evenamide as an add-on to antipsychotics for the management of treatment-resistant schizophrenia (TRS). The data demonstrated that treatment with evenamide was associated with sustained clinically significant benefit that increased throughout the one-year course of… Read More

#News

Child with eczema
#Atopic dermatitis #Clinical trial #Clinical trial design #Innovaderm Research #Phase I trial #RAPT Therapeutics

Clinical data supports oral treatment for atopic dermatitis

A new drug for atopic dermatitis (AD) has demonstrated a positive clinical effect and improvements in various efficacy endpoints after four weeks of treatment. The Phase Ia/IIb study was designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and CCR4 surface receptor occupancy of zelnecirnon in eligible… Read More

#News

Kidneys
#Clinical trial #Immunotherapy #Nantes University Hospital #OSE Immunotherapeutics #Phase I trial #Transplant

High hopes for immunotherapy candidate in renal transplant

OSE Immunotherapeutics and Nantes University Hospital have revealed positive interim data analysis from the FIRsT Phase I/II study evaluating FR104/VEL-101 immunotherapy in renal transplants. The data was presented the Annual Meeting of the Francophone Society of Transplantation (SFT, Société Francophone de Transplantation) held in Brest, France. Read More

#News

Smoking cessation
#Clinical trial #Nicotine addiction #Qnovia #Smoking cessation

Inhaled smoking cessation therapy superior to other treatments

Qnovia has announced positive results from its first in-human study of QN-01, an inhaled smoking cessation therapy. QN-01 is currently being evaluated in the US by the FDA’s Center for Drug Evaluation and Research (CDER) and in the UK by the Medicines and Healthcare Products Regulatory… Read More

#News

Scleroderma
#Autoimmune disease #Certa Therapeutics #Clinical trial #Dermatology #Phase II trial

Scleroderma drug trial shows up to 60% improvement

Biotechnology company Certa Therapeutics has revealed positive Phase II clinical trial data for FT011 in patients with scleroderma. The results were presented at ACR Convergence 2023, the annual scientific meeting of the American College of Rheumatology in San Diego, California (10-15 November 2023). Treatment… Read More

#News

Brain scan
#Cerebral Adrenoleukodystrophy (cALD) #Clinical trial #Minoryx Therapeutics

Next steps for the CALYX trial for cerebral Adrenoleukodystrophy 

Minoryx has announced enrollment of first patients with cerebral Adrenoleukodystrophy (cALD) in the US Phase III clinical trial, CALYX. As part of CALYX, Minoryx is conducting an extensive pre-screening MRI-based campaign aimed at identifying eligible adult X-linked Adrenoleukodystrophy (X-ALD) patients with cALD.   In June… Read More

#News

Multiple myeloma
#Arcellx #CAR-T #Cell therapy #Clinical trial #Haematology #Myeloma #Oncology #Phase I trial

CART-ddBCMA trial shows durable response in myeloma patients

Arcellx has revealed encouraging interim data from its Phase I study of CART-ddBCMA in patients with relapsed or refractory multiple myeloma. The company plans to present new data with a median follow-up of 26.5 months at the 65th American Society of Hematology (ASH) Annual Meeting and… Read More

#Cancer Research #News

Retinitis pigmentosa
#Clinical trial #Kiora Pharmaceuticals #Ophthalmology #Phase I trial #Retinitis pigmentosa

Molecular photoswitch improves visual acuity in retinitis pigmentosa

Topline results from a Phase I/II clinical trial have shown that Kiora’s light-restoring small molecule KIO-301 has the potential to meaningfully improve vision in patients with retinitis pigmentosa (RP). The results of the ABACUS study for Kiora’s intravitreal (IVT) molecular photoswitch were presented at the American… Read More

#News

Hematopoietic cells
#Cancer research #Clinical trial #Gene therapy #MHRA #Paediatrics #Phase I trial #Stem cells #UK

First gene therapy trial for Hunter syndrome opens in Manchester, UK

UK regulatory authorities have approved the first trial of a gene therapy for young children with Hunter syndrome. The UK Medicines and Healthcare Products Regulatory Agency (MHRA), Research Ethics Committee (REC), and Health Research Authority (HRA) have all approved the clinical trial application that was submitted by The University of… Read More

#Editor's Choice #News #Regulatory

#Clinical trial #Clinical trial design #Clinical trials #Drug development

Free clinical trial health check to bring drugs to market faster

A new free service will offer insights in under ten days to sponsors conducting clinical trials, identifying potential ‘zombie trials’ and providing actionable recommendations for failing trials. The Health Check and Trial Rescue Service is an initiative of data software and services company Phesi. The service… Read More

#News

#Clinical trial #Clinical trials #Drug development #Drug discovery #Phase I trial

New podcast: DDW Highlights 17 October 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The buzz with week has been around Phase I trials, with new… Read More

#News

#Clinical trial #Clinical trials #Drug development #Drug discovery #Phase I trial

This week in drug discovery (9-13 October)  

News round-up for 9-13 October by DDW Digital Content Editor Diana Spencer. The buzz with week has been around Phase I trials, with new therapies for lung cancer, geographic atrophy, Parkinson’s, sarcopenia and long Covid demonstrating positive early results or entering clinical trials for the first… Read More

#News

Vaccine vial and syringe
#Clinical trial #Immunology / Virology & Vaccines #Nipah Virus #University of Oxford

UK scientists prepare for Nipah virus clinical trial

The University of Oxford has revealed that researchers are currently in the advanced stages of preparing for a clinical trial of a Nipah vaccine using the ChAdOx1 vector. The scientists are also working with partners to develop antivirals and monoclonals to treat those infected, according to… Read More

#News

CAR-T therapy
#Beam Therapeutics #Cancer research #CAR-T #Clinical trial #Leukaemia #Oncology #T cell activation

First base editing therapeutic for T-ALL/T-LL enters trials

The first quadruplex-edited, allogeneic CAR-T cell therapy candidate has entered clinical trials in the US. The first patient has been treated with Beam Therapeutics’ BEAM-201 as part of a Phase I/II clinical study for the treatment of relapsed/refractory T-cell acute lymphoblastic leukaemia/T-cell lymphoblastic lymphoma (T-ALL/T-LL). Read More

#Cancer Research #News

Hormones in the brain concept
#ALS #Bloom Science #Clinical trial #Phase I trial #Rare disease

Early trial success for Dravet syndrome and ALS therapeutic

Bloom Science has announced positive topline data from a Phase I clinical trial of BL-001, a potential first-in-class therapeutic the company is developing for Dravet syndrome and amyotrophic lateral sclerosis (ALS). In the trial, BL-001 demonstrated a favourable safety profile and was well… Read More

#News

#Clinical trial #Cybin #Major depressive disorder #Psychedelics

Another milestone achieved in major depressive disorder trial 

Cybin, a clinical-stage biopharmaceutical company developing psychedelic-based treatment options for mental health, has completed dosing in Cohort 5 of a Phase II trial evaluating CYB003, an investigational proprietary deuterated analog of psilocybin for the potential treatment of major depressive disorder (MDD).   The dosing was completed with no… Read More

#News